Qiagen NV at Jefferies Healthcare Conference Transcript
I think this is the last thing between you and lunch. So stick with it, and we're going to. My name is Peter Welford. I'm the European Pharma Biotech and Life sciences analyst at Jefferies in London. It's my pleasure to host the next company in this track, which is QIAGEN. We'll be doing a fireside chat. It's our pleasure to have here today, the CFO, Roland, who is going to make a few introductory comments. After that, we'll get straight into Q&A. (Operator Instructions). With that, over to Roland or I should say, we have got John Gilardi as well of IR on the front as well. So with that, over to Roland, and thank you very much.
Yes. Thanks, Peter, for having us. It is always good to see people in person. Yes, let me kick it off a bit with just a brief summary where we are. And I am quite sure that most of you have seen in our press release and the Q1 results, which I do
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
